Yes, I, too, assumed that LE's references to 'new pipeline assets' denoted another drug. However, it's been suggested on this forum the new asset could be a medical device, not a pharmaceutical. (Ostensibly, the device would be used in conjunction with Brilacidin for OM.) Given LE's predilection for spin and exaggeration, I think it would be wise not make unsubstantiated inferences.